The activity of SREBP and downstream FASN was found to be up-regulated in tumor-associated Tregs, which contributed to Tregs functional maturation, further correlated with tumor growth and anti-PD-1 immunotherapy inhibition (55). Here, FASN is linked to neoplasm.